We are live on ! Find out more
GNOM icon

Global X Genomics & Biotechnology ETF
GNOM

58 hedge funds and large institutions have $134M invested in Global X Genomics & Biotechnology ETF in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 15

21% more capital invested

Capital invested by funds: $111M → $134M (+$22.9M)

0.51% more ownership

Funds ownership: 15.76% → 16.27% (+0.51%)

0% more funds holding

Funds holding: 58 → 58 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

Holders
58
Holders Change
–
Holders Change %
0%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
19
Reduced
15
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
+$29.9M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$2.22M
3
Nomura Asset Management
Nomura Asset Management
Japan
+$701K
4
PAG
Private Advisor Group
New Jersey
+$411K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$366K

Top Sellers

Rank Fund Capital Flow
1
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
-$11.1M
2
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
-$858K
3
UBS Group
UBS Group
Switzerland
-$345K
4
BS
Banco Santander
Spain
-$223K
5
AWE
Avidian Wealth Enterprises
Texas
-$150K
Name Holding Trade Value Shares
Change 		Change in
Stake
CG
51
Cutler Group
California
$8K +$4.06K +72 +72%
MIM
52
Macroview Investment Management
Maryland
$7K – – –
ARMC
53
American Research & Management Company
Massachusetts
$2K – – –
BBPWM
54
Blue Bell Private Wealth Management
Pennsylvania
$2K – – –
GWM
55
Geneos Wealth Management
Colorado
$2K – – –
RIA
56
Realta Investment Advisors
Delaware
$2K +$1.86K +33 New
National Bank of Canada
57
National Bank of Canada
Quebec, Canada
$1K – – –
Bank of Montreal
58
Bank of Montreal
Ontario, Canada
$2 -$5.64K -100 -76%
AWE
59
Avidian Wealth Enterprises
Texas
– -$150K -3,076 Closed
CAPTRUST Financial Advisors
60
CAPTRUST Financial Advisors
North Carolina
– -$120K -2,450 Closed
SIC
61
Salem Investment Counselors
North Carolina
– -$19K -388 Closed
BW
62
Bison Wealth
Georgia
– -$12K -255 Closed
FCG
63
Financial Connections Group
California
– -$4K -88 Closed
AIP
64
Ahrens Investment Partners
Louisiana
– -$2K -50 Closed
GFPC
65
Global Financial Private Client
Florida
– -$2.36K -47 Closed
1 2
3

GNOM Hedge Fund Activity: Q3 2022 in Review

58 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q3 2022, worth a combined $134M — up 21% from $111M a quarter earlier.

Fund positioning in GNOM was balanced in Q3 2022: 7 funds opened new positions, 7 closed out, 19 added to existing stakes and 15 trimmed.

The largest buyer was Northwestern Mutual Wealth Management, adding an estimated $29.9M. The largest seller was PNC Financial Services Group, cutting an estimated $11.1M.

  • 58 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $134M of Global X Genomics & Biotechnology ETF stock for Q3 2022, up 21% quarter-over-quarter.
  • 7 funds opened new Global X Genomics & Biotechnology ETF positions in Q3 2022 and 7 closed out, a net change of 0 holders.
  • The largest Global X Genomics & Biotechnology ETF buyer in Q3 2022 was Northwestern Mutual Wealth Management, an estimated $29.9M added.
  • The largest Global X Genomics & Biotechnology ETF seller in Q3 2022 was PNC Financial Services Group, an estimated $11.1M sold.

Based on aggregated 13F filings for Q3 2022.